SEVERE HYPERTRIGLYCERIDEMIA
Clinical trials for SEVERE HYPERTRIGLYCERIDEMIA explained in plain language.
Never miss a new study
Get alerted when new SEVERE HYPERTRIGLYCERIDEMIA trials appear
Sign up with your email to follow new studies for SEVERE HYPERTRIGLYCERIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New injection shows promise for dangerous high fat levels in blood
Disease control CompletedThis study tested a new drug called DR10624 in 79 adults with severely high triglycerides, a type of blood fat that raises heart risk. The drug is given as a shot under the skin and aims to lower triglyceride levels over 12 weeks. The trial compared the drug to a placebo to see i…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE2 • Sponsor: Zhejiang Doer Biologics Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 12:09 UTC
-
Two shots could slash dangerous fat levels in blood
Disease control CompletedThis study tested an experimental drug called ARO-APOC3 in 229 adults with severely high triglycerides (a type of blood fat). Participants received two injections of the drug or a placebo. The goal was to see if the drug safely lowers triglyceride levels and reduces related prote…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 12:04 UTC
-
New shot cuts dangerous fat levels in half for High-Risk patients
Disease control CompletedThis study tested a new medicine called olezarsen in 446 adults with very high levels of triglycerides (a type of fat in the blood). Participants received either the drug or a placebo as a shot under the skin. The main goal was to see if olezarsen could safely lower triglyceride …
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New drug shows promise for lowering dangerous fat levels in heart patients
Disease control CompletedThis study tested an experimental drug called olezarsen in 154 adults with high triglycerides (a type of fat in the blood) and either heart disease or very high triglycerides. The goal was to see if the drug could safely lower triglyceride levels more than a placebo over 6 and 12…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE2 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New shot cuts dangerous fat levels in blood, study shows
Disease control CompletedThis study tested a new medicine called olezarsen in 617 adults with severely high triglycerides, a type of blood fat that raises the risk of heart problems and pancreatitis. Participants received either the drug or a placebo as a shot under the skin. The main goal was to see if …
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 18, 2026 12:01 UTC